Sofinnova Venture Partners IX, L.P.'s Net Worth

-$28.3 Million

Who is Sofinnova Venture Partners IX, L.P.?

Sofinnova Venture Partners IX, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Entasis Therapeutics Holdings Inc., Iterum Therapeutics plc, Checkmate Pharmaceuticals, Inc., Galera Therapeutics, Inc., NextCure, Inc., and aTYR PHARMA INC.

SEC CIK

Sofinnova Venture Partners IX, L.P.'s CIK is 0001612133

Past Insider Trading and Trends

2019 was Sofinnova Venture Partners IX, L.P.'s most active year for acquiring shares with 8 total transactions. Sofinnova Venture Partners IX, L.P.'s most active month to acquire stocks was the month of April. 2019 was Sofinnova Venture Partners IX, L.P.'s most active year for disposing of shares, totalling 6 transactions. Sofinnova Venture Partners IX, L.P.'s most active month to dispose stocks was the month of April. 2019 saw Sofinnova Venture Partners IX, L.P. paying a total of $20,512,500.00 for 5,755,568 shares, this is the most they've acquired in one year. In 2020 Sofinnova Venture Partners IX, L.P. cashed out on 25,397,974 shares for a total of $812,080.00, their largest year based on trade value.